<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is the third leading cause of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:hpo ids='HP_0011420'>death</z:hpo> in the US, and stage at diagnosis is the primary prognostic factor </plain></SENT>
<SENT sid="1" pm="."><plain>To date, the interplay between geographic place and individual characteristics such as <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stage with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> survival is unexplored </plain></SENT>
<SENT sid="2" pm="."><plain>We used a Bayesian geosurvival statistical model to evaluate whether the spatial patterns of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> survival at the census tract level varies by stage at diagnosis (in situ/local, regional, distant), controlling for patient characteristics, surveillance test use, and treatment using linked 1991-2005 SEER-Medicare data of patients ≥ 66 years old in two US metropolitan areas </plain></SENT>
<SENT sid="3" pm="."><plain>The spatial pattern of survival varied by stage at diagnosis for both <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> sites and registries </plain></SENT>
<SENT sid="4" pm="."><plain>Significant spatial effects were identified in <z:hpo ids='HP_0000001'>all</z:hpo> census tracts for <z:hpo ids='HP_0003003'>colon cancer</z:hpo> and the majority of census tracts for <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Geographic disparities appeared to be highest for distant-stage <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Compared to those with in situ/local stage in the same census tracts, patients with distant-stage <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> were at most 7.73 times and 4.69 times more likely to die of colon and <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e>, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Moreover, frailty areas for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> at in situ/local stage more likely have a higher relative risk at regional stage, but not at distant stage </plain></SENT>
<SENT sid="8" pm="."><plain>We identified geographic areas with excessive risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:hpo ids='HP_0011420'>death</z:hpo> and demonstrated that spatial patterns varied by both <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> type and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stage </plain></SENT>
<SENT sid="9" pm="."><plain>More research is needed to understand the moderating pathways between geographic and individual-level factors on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> survival </plain></SENT>
</text></document>